Global Vascular Screening Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Portable and Standalone.

By End User;

Hospitals, Diagnostic Centres/Clinics, and Other End Users.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn210257148 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Vascular Screening Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Vascular Screening Devices Market was valued at USD 2,535.41 million. The size of this market is expected to increase to USD 3,684.44 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.5%.

The Global Vascular Screening Devices Market encompasses a wide range of medical devices designed to detect and monitor vascular conditions, primarily focusing on cardiovascular diseases. These devices are crucial for early diagnosis and prevention of serious health issues such as stroke, aneurysm, and peripheral artery disease. With cardiovascular diseases being one of the leading causes of death globally, the importance of effective vascular screening cannot be overstated.

Technological advancements have significantly enhanced the capabilities of vascular screening devices, making them more accurate, efficient, and user-friendly. Innovations such as portable devices, integration with artificial intelligence, and telehealth capabilities have expanded the market’s reach and applicability. These advancements have not only improved patient outcomes but also made screening more accessible and convenient, particularly in remote and underserved areas.

The market is driven by several factors, including the growing aging population, rising incidence of cardiovascular diseases, and increasing healthcare expenditure. However, it also faces challenges such as high device costs, regulatory hurdles, and a shortage of skilled professionals. Despite these challenges, the market holds substantial growth potential, particularly with the increasing focus on preventive healthcare and the expansion into emerging markets.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Vascular Screening Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population increase
        2. Rising cardiovascular diseases
        3. Technological advancements rapid
        4. Early diagnosis importance
        5. Healthcare expenditure growth
      2. Restraints
        1. High device costs
        2. Regulatory approval challenges
        3. Limited awareness programs
        4. Reimbursement policy issues
        5. Skilled professionals shortage
      3. Opportunities
        1. Emerging market expansion
        2. Telehealth integration potential
        3. AI technology adoption
        4. Portable device development
        5. Public health initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Vascular Screening Devices Market, By Product Type, 2021 - 2031 (USD Million)
      1. Portable
      2. Standalone
    2. Global Vascular Screening Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Centres/Clinics
      3. Others
    3. Global Vascular Screening Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. GE Healthcare
      2. Philips Healthcare
      3. Siemens Healthineers
      4. Canon Medical Systems
      5. Fujifilm Holdings Corporation
      6. Terumo Corporation
      7. Medtronic PLC
      8. Boston Scientific Corporation
      9. Abbott Laboratories
      10. Koninklijke Philips N.V
  7. Analyst Views
  8. Future Outlook of the Market